The results exhibited that the triple therapy group, consisting of BIBR1532 in combination with IR and Anti-PD-L1, displayed the most pronounced inhibitory effect on tumour growth when compared to the IR combined with Anti-PD-L1 group and the IR combined with BIBR1532 group. This evidence concerns the gene CD274 and neoplasm.